SF3B1 and myelodysplastic syndrome: In a recent study, it has been shown that the combined expression of small noncoding RNAs (sncRNAs) in MDS patients harboring SF3B1 and DNMT3A mutations can predict response to 5-AZA as well as define survival (143).